Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase 3 3Phase EARLY_PHASE1 2Phase NA 1Phase 2 1

Status

Completed 5Unknown 4Terminated 3Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Pain 1Neoplasms 1Mucositis 1Head and Neck Neoplasms 1Cancer: Breakthrough Pain 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 48Radiotherapy 47Docetaxel 41Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Drug Therapy 14Irinotecan 13Imatinib Mesylate 13Filgrastim 13Zoledronic Acid 12Radiosurgery 12Erlotinib Hydrochloride 12Trastuzumab 11Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Ketamine × Clear all
NCT04176419 2024-11-12

Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery

Case Comprehensive Cancer Center

Phase 3 Terminated
30 enrolled
Head & Neck

Head and Neck Neoplasms

NCT02591017 2018-11-13

ONKEMI

University Hospital, Basel, Switzerland

Phase 3 Terminated
11 enrolled

Cancer: Breakthrough Pain

NCT00224692 2006-10-26

Analgesic Effect in Children of Low-Dose Ketamine for Mucositis Treated by Patient-Controlled Analgesia With Morphine

Assistance Publique - Hôpitaux de Paris

Phase 3 Terminated
50 enrolled
Other

Neoplasms, Pain, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡